The Molecular Glue Drug Development Summit returns to Boston with fresh insights and opportunities! With powerhouse partnerships lighting up the industry—like Biogen & Neomorph, Inc.’s groundbreaking ...
Don’t stop Monte Rosa Therapeutics now. The Boston-based biotech is having a ball after signing a deal with Novartis to the tune of $150 million for a molecular glue degrader, developed using the ...
Between the live-action Barbie movie coming out last summer, Glinda wearing all things pink in the upcoming Wicked movie, and coquette decor in general having a moment, I feel like people are ...